New study reveals cefoxitin as effective first-line treatment for intraamniotic infections Post author: Post published:February 5, 2024 Post category:uncategorized The effectiveness of Cefoxitin in the treatment of Endometritis and Intraamniotic Infections (IAI). You Might Also Like Report: Primary care doctor shortage threatens New Jersey residents February 9, 2024 Mad2 expression levels with chromosomal abnormalities can be a biomarker for esophageal cancer February 12, 2024 Flaws in study design may limit detection of cognitive effects in diet trials November 28, 2024
Mad2 expression levels with chromosomal abnormalities can be a biomarker for esophageal cancer February 12, 2024